Steady-State Kinetic Characterization of Kinase Activity and Requirements for Mg2+ of Interleukin-1 Receptor-Associated Kinase-4
Steady-State Kinetic Characterization of Kinase Activity and Requirements for Mg2+ of Interleukin-1 Receptor-Associated Kinase-4
复制标题
DOI:
10.1021/bi901609m
复制
发表时间:
2010-02-23
期刊:
影响因子:
2.9
通讯作者:
Swinney, David C.
中科院分区:
文献类型:
--
作者:
Hekmat-Nejad, Mohammad;Cai, Terrence;Swinney, David C.
Interleukin-1 receptor-associated kinase-4 (IRAK-4) is a Ser/Thr-specific protein kinase that plays a critical role in intracellular signaling cascades mediated by Toll-like and interleukin-1 (IL-1) receptors. Despite a growing body of information oil the physiological functions of IRAK-4, its kinase activity remains poorly studied. The present study entails characterization of the steady-state kinetic properties and Mg2+ requirements of full-length, recombinant human IRAK-4 preactivated by incubation with MgATP. In the presence of 20 mM Mg2+, activated IRAK-4 herein is demonstrated to phosphorylate a peptide substrate (IRAK-1 peptide), derived from the activation loop of IRAK-1, with a k(cat) of 30 +/- 2.9 s(-1) and K-m values of 668 +/- 120 and 852 +/- 273 mu M for ATP and the peptide, respectively. Two-substrate, dead-end and product inhibition data, using analogues of ATP, are consistent with both a sequential ordered kinetic mechanism with ATP binding to the enzyme prior to the peptide and a sequential random mechanism. Investigation of the Mg2+ requirements for phosphoryl transfer activity or IRAK-4 revealed that more than one Mg2+ ion interacts with the enzyme and that the enzyme is maximally active in the presence of 5-10 mM free Mg2+ While one divalent metal, as part of a chelate complex with ATP, is essential for catalysis, kinetic evidence is provided to show that uncomplexed Mg2+ further enhances the catalytic activity of IRAK-4 by bringing about an similar to 3-fold increase in k(cat) and an similar to 6-fold reduction in the K-m for ATP and by rendering the interaction between the nucleotide and peptide substrate binding sites less antagonistic.